|
PART
|
96T
|
48T
|
STORAGE
|
|
Pre-Coated Plate
|
8×12
|
8×6
|
4 ℃ / -20 ℃
|
|
Pre-Mixed Standards
|
2 vials
|
1 vial
|
4 ℃ / -20 ℃
|
|
Pre-Mixed Biotinylated Antibody (1:100)
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Enzyme Conjugate(1:100)
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Enzyme Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Antibody Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Standard Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Sample Diluent
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Washing Buffer (1:25)
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Color Reagent A
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Color Reagent B
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Color Reagent C
|
1 vial
|
1 vial
|
4 ℃ / -20 ℃
|
|
Manual
|
1 set
|
1 set
|
RT
|
Place collected whole blood in refrigerator at 4 ℃ overnight. Then centrifuge for 10mins at 1000-3000 rpm. Take supernatant and either test immediately or place samples at -20 ℃/-80 ℃(1-3 months) for storage.
Take plasma where EDTA, sodium citrate, or heparin has been added as anticoagulant. Mix well. Centrifuge mixture for 10mins at 1000-3000 rpm. Take supernatant and test immediately or place samples at -20 ℃ /-80 ℃ (1-3 months) for storage.
Take tissue slices which have been washed in 0.01 M PBS and then a tissue protein extraction reagent has been added according to proportion of 1 g to 5-10 mL and then mixed on ice bath. After sufficient homogenization, please then centrifuge for 10mins at 5000-10000 rpm. Take supernatant for immediate testing, or place samples at -20 ℃/-80 ℃ (1-3 months) for storage.
Centrifuge for 10 mins at 1000-3000 rpm. Take supernatant for immediate testing, or place samples at -20 ℃/-80 ℃ (1-3 months) for storage.
Centrifuge for 10mins at 1000-3000 rpm. Take supernatant for immediate testing, or place samples at -20 ℃/-80 ℃ (1-3 months) for storage.
|
TYPICAL DATA
|
Reference STD1
|
Reference STD2
|
Reference STD3
|
Reference STD4
|
Reference STD5
|
Reference STD6
|
Reference STD7
|
Reference STD8
|
|
PG-F, pg/mL
|
500
|
250
|
125
|
62.5
|
31.25
|
15.625
|
7.813
|
0
|
|
PG-F, OD.
|
2.291
|
1.222
|
0.714
|
0.385
|
0.216
|
0.122
|
0.065
|
0.043
|
|
PGF1α, pg/mL
|
500
|
250
|
125
|
62.5
|
31.25
|
15.625
|
7.813
|
0
|
|
PGF1α, OD.
|
3.033
|
1.736
|
0.955
|
0.525
|
0.295
|
0.164
|
0.087
|
0.058
|
|
PGF2α, pg/mL
|
500
|
250
|
125
|
62.5
|
31.25
|
15.625
|
7.813
|
0
|
|
PGF2α, OD.
|
3.578
|
2.09
|
1.105
|
0.639
|
0.344
|
0.189
|
0.106
|
0.074
|
|
PGH2, pg/mL
|
500
|
250
|
125
|
62.5
|
31.25
|
15.625
|
7.813
|
0
|
|
PGH2, OD.
|
3.203
|
1.743
|
0.969
|
0.554
|
0.296
|
0.165
|
0.091
|
0.063
|
STANDARD CURVE
To assess linearity of the assay, samples were spiked with high concentrations of Rat PG-F, PGF1α, PGF2α, PGH2 and diluted with the appropriate calibrator diluent to produce samples with values within the dynamic range of the assay.
|
Matrix
|
Scope %
|
Average % Recovery Rate
|
|
serum(n=5)
|
83-94
|
88.5
|
|
EDTA plasma(n=5)
|
94-97
|
95.5
|
|
Cell Culture Media(n=5)
|
92-100
|
96
|
|
Within-Run Precision
|
Inter-Batch Precision
|
|||||
|
Sample
|
1
|
2
|
3
|
1
|
2
|
3
|
|
n
|
20
|
20
|
20
|
20
|
20
|
20
|
|
CV%
|
6.7
|
6.3
|
6.8
|
9
|
7.7
|
7.9
|